James I. Mullins

Active 1981–2025

158
Papers
27,387
Citations
99
h-index
153
i10-index

Citations

Citations per year for James I. Mullins1967: 2 citations1971: 1 citations1981: 2 citations1982: 3 citations1983: 9 citations1984: 61 citations1985: 26 citations1986: 29 citations1987: 30 citations1988: 72 citations1989: 59 citations1990: 53 citations1991: 59 citations1992: 51 citations1993: 50 citations1994: 82 citations1995: 71 citations1996: 93 citations1997: 100 citations1998: 114 citations1999: 125 citations2000: 131 citations2001: 171 citations2002: 158 citations2003: 139 citations2004: 189 citations2005: 184 citations2006: 240 citations2007: 273 citations2008: 326 citations2009: 262 citations2010: 255 citations2011: 289 citations2012: 294 citations2013: 183 citations2014: 192 citations2015: 191 citations2016: 173 citations2017: 104 citations2018: 119 citations2019: 411 citations2020: 348 citations2021: 300 citations2022: 245 citations2023: 191 citations2024: 331 citations2025: 179 citations2026: 5 citations1968–1970: no citations, so these years are not shown1972–1980: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,071 citing papers, 39.2% of this breakdownUnited Kingdom: 613 citing papers, 7.8% of this breakdownFrance: 366 citing papers, 4.7% of this breakdownGermany: 310 citing papers, 3.9% of this breakdownCanada: 301 citing papers, 3.8% of this breakdownSouth Africa: 271 citing papers, 3.5% of this breakdownAustralia: 228 citing papers, 2.9% of this breakdownSpain: 220 citing papers, 2.8% of this breakdownSwitzerland: 218 citing papers, 2.8% of this breakdownChina: 207 citing papers, 2.6% of this breakdownItaly: 171 citing papers, 2.2% of this breakdownNetherlands: 170 citing papers, 2.2% of this breakdown
0%39.2%Other 21.6%

Fields

  • Immunology and Microbiology57.5%
  • Medicine20.4%
  • Biochemistry, Genetics and Molecular Biology16.8%
  • Agricultural and Biological Sciences2.3%
  • Environmental Science0.7%
  • Computer Science0.5%
  • Other1.8%

Topics

  • HIV Research and Treatment20.3%
  • HIV/AIDS drug development and treatment8.6%
  • HIV/AIDS Research and Interventions7.5%
  • Immune Cell Function and Interaction6%
  • T-cell and B-cell Immunology2.8%
  • vaccines and immunoinformatics approaches2.3%
  • Other52.5%

Coauthors

All papers

Open in search
  1. Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Simbarashe Takuva, Margarita M. Gomez Lorenzo, David Burns, Nicole Espy, April K. Randhawa, Nidhi Kochar, Estelle Piwowar‐Manning, Deborah Donnell, Nirupama Sista, P. Andrew, James G. Kublin, Glenda Gray, Julie E. Ledgerwood, John R. Mascola, Myron S. Cohen - New England Journal of Medicine 2021 cited by 539

  2. Proliferation of cells with HIV integrated into cancer genes contributes to persistent infection

    Authors: , , , , , , , , , - Science 2014 cited by 709

  3. Neutralization titer biomarker for antibody-mediated prevention of HIV-1 acquisition

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kelvin Chiong, Georgia D. Tomaras, P. Andrew, Bryan T. Mayer, Daniel B. Reeves, Magdalena E. Sobieszczyk, Nigel Garrett, Jorge Sánchez, Cynthia L. Gay, Joseph Makhema, Carolyn Williamson, James I. Mullins, John Hural, Myron S. Cohen, Lawrence Corey, David C. Montefiori, Lynn Morris - Nature Medicine 2022 cited by 126

  4. In-depth single-cell analysis of translation-competent HIV-1 reservoirs identifies cellular sources of plasma viremia

    Authors: , , , , , , , , , , , - Nature Communications 2021 cited by 82

  5. Persistence of HIV in Gut‐Associated Lymphoid Tissue despite Long‐Term Antiretroviral Therapy

    Authors: , , , , , , , , , , , , , - The Journal of Infectious Diseases 2008 cited by 564

  6. Neutralization profiles of HIV-1 viruses from the VRC01 Antibody Mediated Prevention (AMP) trials

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michael S. Seaman, Lawrence Corey, Myron S. Cohen, John Hural, M. Juliana McElrath, James I. Mullins, David C. Montefiori, Penny L. Moore, Carolyn Williamson, Lynn Morris - PLoS Pathogens 2023 cited by 56

  7. Consistent Viral Evolutionary Changes Associated with the Progression of Human Immunodeficiency Virus Type 1 Infection

    Authors: , , , , , , , , , , , - Journal of Virology 1999 cited by 956

  8. CD8+ T-cell responses to different HIV proteins have discordant associations with viral load

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2006 cited by 1,013

  9. ViroBLAST: a stand-alone BLAST web server for flexible queries of multiple databases and user's datasets

    Authors: , , , , - Bioinformatics, Bioinform. 2007 cited by 270

  10. Pharmacokinetic serum concentrations of VRC01 correlate with prevention of HIV-1 acquisition

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , P. Andrew, José A. Hidalgo, Jesse N. Clark, Fatima Laher, Catherine Orrell, Ian Frank, Pedro Gonzáles, Srilatha Edupuganti, Nyaradzo Mgodi, Lawrence Corey, Lynn Morris, David C. Montefiori, Myron S. Cohen, Peter B. Gilbert, Georgia D. Tomaras - EBioMedicine 2023 cited by 33

  11. CD39/Adenosine Pathway Is Involved in AIDS Progression

    Authors: , , , , , , , , , , , , , , , , , - PLoS Pathogens 2011 cited by 172

  12. HIV-Specific Probabilistic Models of Protein Evolution

    Authors: , , , , , - PLoS ONE 2007 cited by 134

  13. Droplet-microfluidics-assisted sequencing of HIV proviruses and their integration sites in cells from people on antiretroviral therapy

    Authors: , , , , , , , , - Nature Biomedical Engineering 2022 cited by 43

  14. Comparative immunogenicity of an mRNA/LNP and a DNA vaccine targeting HIV gag conserved elements in macaques

    Authors: , , , , , , , , , , , , , , - Frontiers in Immunology 2022 cited by 29

  15. Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature 2004 cited by 849

  16. Acyclovir and Transmission of HIV-1 from Persons Infected with HIV-1 and HSV-2

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Etienne Karita, William Kanweka, Sinéad Delany, Helen Rees, Bellington Vwalika, Wendy Stevens, Mical S. Campbell, Katherine K. Thomas, Robert W. Coombs, Rhoda Ashley Morrow, William L. H. Whittington, M. Juliana McElrath, Linda Barnes, Renée Ridzon, Lawrence Corey - New England Journal of Medicine 2010 cited by 526

  17. Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mark S. deSouza, Sorachai Nitayaphan, Supachai Rerks‐Ngarm, Merlin L. Robb, Jason S. McLellan, Ivelin S. Georgiev, Peter D. Kwong, Jonathan M. Carlson, Nelson L. Michael, William R. Schief, Peter B. Gilbert, James I. Mullins, Jérôme H. Kim - Nature 2012 cited by 422

  18. Evidence that Low-Level Viremias during Effective Highly Active Antiretroviral Therapy Result from Two Processes: Expression of Archival Virus and Replication of Virus

    Authors: , , , , , , , , , , - Journal of Virology 2005 cited by 221

  19. Africa-specific human genetic variation near CHD1L associates with HIV-1 load

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , James J. Goedert, David B. Goldstein, David W. Haas, Joshua T. Herbeck, Eric O. Johnson, Pontiano Kaleebu, William Kilembe, Gregory D. Kirk, Neeltje A. Kootstra, Alex H. Kral, Olivier Lambotte, Ma Luo, S. Mallal, Javier Martínez‐Picado, Laurence Meyer, José M. Miró, Pravi Moodley, Ayesha A. Motala, James I. Mullins, Kireem Nam, Niels Obel, Fraser Pirie, Francis A. Plummer, Guido Poli, Matt A. Price, Andri Rauch, Ioannis Theodorou, Alexandra Trkola, Bruce D. Walker, Cheryl A. Winkler, Jean‐François Zagury, Stephen B. Montgomery, Angela Ciuffi, Judd F. Hultquist, Steven M. Wolinsky, Gordon Dougan, Andrew Lever, Deepti Gurdasani, Harriet C. T. Groom, Manjinder S. Sandhu, Jacques Fellay - Nature 2023 cited by 25

  20. Prevention efficacy of the broadly neutralizing antibody VRC01 depends on HIV-1 envelope sequence features

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Nonkululeko Ndabambi, Ruwayhida Thebus, Shelly Karuna, Lynn Morris, David C. Montefiori, John Hural, Myron S. Cohen, Lawrence Corey, Morgane Rolland, Peter B. Gilbert, Carolyn Williamson, James I. Mullins - National Academy of Sciences, Proceedings of the National Academy of Sciences 2024 cited by 20

  21. Lethal mutagenesis of HIV with mutagenic nucleoside analogs

    Authors: , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 1999 cited by 362

  22. A human immune data-informed vaccine concept elicits strong and broad T-cell specificities associated with HIV-1 control in mice and macaques

    Authors: , , , , , , , , , , , , , , , , , , , , - Journal of Translational Medicine 2015 cited by 97

  23. Cells producing residual viremia during antiretroviral treatment appear to contribute to rebound viremia following interruption of treatment

    Authors: , , , , , , , - PLoS Pathogens 2020 cited by 40

  24. Evidence for Human Immunodeficiency Virus Type 1 Replication In Vivo in CD14 + Monocytes and Its Potential Role as a Source of Virus in Patients on Highly Active Antiretroviral Therapy

    Authors: , , , , , , , , - Journal of Virology 2002 cited by 295